Latest news
Starling Oncology (STLN) Stock Rerates On Cash Gains As Margin Risks Linger - simplywall.stsimplywall.st · Sat, 08 Aug 2026 03:40:57 GMTB. Riley Adjusts Price Target on Starling Oncology to $11 From $8, Maintains Buy Rating - MoomooMoomoo · Fri, 07 Aug 2026 23:06:17 GMTOncology Institute Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 18:04:22 GMTNon-controlling/minority interest of Starling Oncology, Inc. – NASDAQ:STLNW - TradingViewTradingView · Fri, 07 Aug 2026 13:59:59 GMTEBIT of Starling Oncology, Inc. – NASDAQ:STLNW - TradingViewTradingView · Fri, 07 Aug 2026 07:56:39 GMTDiscontinued operations of Starling Oncology, Inc. – NASDAQ:STLNW - TradingViewTradingView · Fri, 07 Aug 2026 07:51:27 GMTAfter tax other income/expense of Starling Oncology, Inc. – NASDAQ:STLNW - TradingViewTradingView · Fri, 07 Aug 2026 07:14:23 GMTEnterprise value to revenue forward of Starling Oncology, Inc. – NASDAQ:STLNW - TradingViewTradingView · Fri, 07 Aug 2026 05:48:13 GMT